Children’s EUA Approved Despite Lack Of Long Term Studies
The FDA’s Center For Biologics Evaluation And Research Held It’s 170th Meeting Of The Vaccines And Related Biological Products Advisory Committee Virtually On October 26th, 2021 To Discuss Granting An Emergency Use Authorization (EUA) For Pfizer-Biontech mRNA Covid-19 Vaccine For Children 5-11 Years Old.
Read more